stockrowAmylyx Pharmaceuticals, Inc.
AMLX Healthcare Drug Manufacturers Specialty & Generic
Amylyx Pharmaceuticals, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $87.4 million, down 77.1% from fiscal 2023.
- Revenue
- −100.6%
- EPS
- +15.2%
- Free cash flow
- −24.5%
Quarter to June 2026, against a year earlier
Follow AMLX
Alert me
Amylyx Pharmaceuticals, Inc. (AMLX) Net margin
Amylyx Pharmaceuticals, Inc.'s net margin over the twelve months to 30 June 2026 was 0.00%, down 0.0 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −30,853.0% (fiscal 2021) to 12.9% (fiscal 2023); the current reading is higher than 83% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of −2.45% and in line with the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 345.36 |
| FY2024 | −345.4% | (358.30) |
| FY2023 | 12.9% | 905.32 |
| FY2022 | −892.4% | 29,960.60 |
| FY2021 | −30,853.0% | (24,348.36) |
| FY2020 | −6,504.6% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 0.00% | 0.00 |
| Mar 2026 | 0.00% | 0.00 |
| Dec 2025 | 0.00% | 0.00 |
| Sep 2025 | 0.00% | 0.00 |
| 18 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| SUPN Indivior Pharmaceuticals Inc. compare | 32.9% |
| LQDA Liquidia Corporation compare | 30.7% |
| PBH Prestige Consumer Healthcare Inc. compare | 13.3% |
| AMLX Amylyx Pharmaceuticals, Inc. | 0.00% |
| RGC Regencell Bioscience Holdings Limited compare | 0.00% |
| HIMS Hims & Hers Health, Inc. compare | −5.51% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −23.6% |
| TRLV Trulieve Cannabis Corp. compare | −41.2% |
| PRGO Perrigo Company plc compare | −43.3% |
| Drug Manufacturers Specialty & Generic industry median | −2.45% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on AMLX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement